Logotype for CRH plc

CRH (CRH) H2 2013 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for CRH plc

H2 2013 earnings summary

19 Nov, 2026

Executive summary

  • 2013 sales were flat at €18bn; EBITDA of €1.48bn came slightly ahead of guidance, and EPS was just under €0.60.

  • 2013 was described as the earnings trough; H2 revenue and EBITDA improved, with stabilization signs in Europe and stronger momentum in the Americas.

  • Portfolio review targets higher returns through focused capital allocation and reallocation, with a goal of restoring group returns to historical peaks of 12%–13%.

Financial highlights

  • EBITDA movement reflected €197m of cost savings, ahead of the prior €125m expectation; H2 trading was €20m ahead YoY after a €105m shortfall at June.

  • Operating cash generation was just under €750m; CapEx was €500m, and working capital closed at 11.2% of sales.

  • Cash balance was €2.5bn and committed facilities almost €2bn, for €4.5bn total liquidity; net debt was below €3bn, about 2x EBITDA.

  • A €755m impairment charge related to identified exit businesses; 2012 comparisons included €61m of pension-curtailment and CO₂ gains versus €32m in 2013.

Outlook and guidance

  • 2014 expected to bring growth at a moderate pace; U.S. residential recovery to broaden into non-residential, while infrastructure was expected broadly flat.

  • Europe expected to show positive momentum, with early-2014 stabilization; country outlook ranged from slightly up in Switzerland, Belgium, Germany and Poland to flat in the Netherlands and Finland.

  • 2014 CapEx expected near €500m and finance costs near €300m; expected tax rate 22%–24%.

  • Cost savings target for 2012–15 was raised to €535m from €450m; 2014–15 targets remained unchanged.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from CRH